8.78BMarket Cap32.27P/E (TTM)
69.250High67.940Low1.26MVolume68.900Open69.230Pre Close86.30MTurnover1.00%Turnover Ratio36.78P/E (Static)128.28MShares80.67052wk High-59.85P/B8.65BFloat Cap48.06052wk Low--Dividend TTM126.51MShs Float80.670Historical High--Div YieldTTM1.89%Amplitude13.560Historical Low68.454Avg Price1Lot Size
BellRing Brands Stock Forum
BellRing's Aggressive Buyback Strategy: $300M New Authorization Following $288M Program Success
In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!
In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (Delisted) (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
• $SpringWorks Therapeutics (SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences (ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen (OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Champion Homes (SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase (NTES.US)$ +4.1% (In...
From the perspective of position preference
BlackRock favors technology stocks, accounting for 24.78% of the total position. It was followed by financials and healthcare stocks, which acco...
No comment yet